Literature reviews  >  Articles for review > O'Neill et al. Real-time nested multiples PCR for detection... 

 

About SDI
Mission
Diagnostic
Priorities
Workplan
Activities
Newsletters
Grants
Publications
Journal articles
Guidelines
Manuals
Reports
Literature reviews
Contact us

A real-time nested multiplex PCR for the detection of HSV types 1 and 2 and VZV provides a specific result without the need for further typing.

Real-time nested multiplex PCR for the detection of Herpes simplex virus types 1 and 2 and Varicella zoster virus.
O'Neill HJ, Wyatt DE, Coyle PV, McCaughey C, Mitchell F.
Journal of Medical Virology 2003;71:557-560.

 

Summary:

Question
How well does a real-time nested multiplex PCR assay compare to a conventional multiplex nested PCR using agarose gel electrophoresis for the detection and typing of HSV types 1 and 2 and VZV in cutaneous lesions?

Design
A nested, multiplex PCR using agarose gel electrophoresis for the detection and typing of HSV types 1 and 2 and VZV, which had proven sensitivity and specificity, was adapted to a real-time nested multiplex PCR using the LightCycler system to identify amplicons by melting temperatures.

Participants
One hundred forty-nine specimens were tested by both PCR methods. One hundred two were tested as they arrived in the laboratory; 47 archived specimens that had been stored at -20oC for between 1 and 12 months were also tested. These 47 were selected based on previously determined results. Seventeen, 28, and 2 were HSV-2 positive, VZV positive, and negative, respectively. Specimens were obtained from 70 males, 68 females, and 11 from patients for which gender was not specified. Penile, vulval, vaginal, or anal specimens were collected from 81 patients attending genitourinary medicine clinics and non-genital vesicular lesion specimens were collected from 68 other patients.

Description of Tests and Diagnostic Standard
Swabs were placed in 2 ml of viral transport medium and the specimens were vortexed. Anogenital specimens were tested without extraction. Non-genital specimens were extracted using the Qiagen DNA blood kit. The standard routine nested, multiplex PCR used primers targeting 221 and 138 bp fragments of the HSV-1 gpD gene, 221 and 101 bp fragments of the HSV-2 gpG gene, and 646 and 552 bp fragments of the VZV ORF38. The assay had previously been optimized with respect to primer and MgCl2 concentration and annealing temperature. For first round PCR, 2μl of DNA was added to 8μl of PCR reaction mix. For second round PCR, 0.2μl of first round product was added to 9.8μl of reaction mix. Both the first and second round products were run on 2% agarose gels that were stained with ethidium bromide. The first round of the real-time nested multiplex PCR was carried out using the same procedure as for the standard PCR. The second round was performed in a LightCycler (Roche, Lewes, UK), with modified VZV primers that amplied a smaller amplicon (165 bp) and SYBR green. Melting curve analysis was performed after amplification to identify the PCR amplicon. Positive and negative controls were included for each target in each test run.

Main Outcome Measures
The results of the standard nested multiplex PCR assay were compared to those of the real-time nested multiplex PCR assay for 149 swab specimens.

Main Results
The results of the standard and real-time PCR assays are shown in the table. The results of both assays were the same except for one specimen, which was repeatedly HSV-2 positive by the real-time assay and repeatedly negative by the standard assay. Each target gave a distinct Tm on melting curve analysis.

Authors' Conclusions
The real-time assay differentiated between HSV-1, HSV-2, and VZV without further testing of the amplified products and gave a similar level of sensitivity and specificity as the standard assay. The results of the real-time assay were available approximately 2 hr earlier than the standard assay, and allowed product detection and identification in a single, closed tube system, reducing the possibility of specimen contamination by amplified products.

Source of funding: Not given

For correspondence: Hugh J. O'Neill, Regional Virus Laboratory, Royal Victoria Hospital, Belfast, BT12 6BA. E-mail address: hugh.oneill@bll.n-i.nhs.uk

   

about SDI | newsletters | grants | publications | literature reviews

WHO Home - WHO Search - TDR Home - SDI Home - SDI Contact us
(c) WHO/OMS 2001